Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance

• Gian Luca Rampioni Vinciguerra,
• Marina Capece,
• Rosario Distefano,
• Giovanni Nigita,
• Andrea Vecchione,
• Francesca Lovat,
• Carlo M. Croce

Affiliations

Gian Luca Rampioni Vinciguerra

Department of Cancer Biology and Genetics and Comprehensive Cancer Center, The Ohio State University

Marina Capece

Department of Cancer Biology and Genetics and Comprehensive Cancer Center, The Ohio State University

Rosario Distefano

Department of Cancer Biology and Genetics and Comprehensive Cancer Center, The Ohio State University

Giovanni Nigita

Department of Cancer Biology and Genetics and Comprehensive Cancer Center, The Ohio State University

Andrea Vecchione

Department of Clinical and Molecular Medicine, University of Rome ‘Sapienza’, Sant’Andrea Hospital

Francesca Lovat

Department of Cancer Biology and Genetics and Comprehensive Cancer Center, The Ohio State University

Carlo M. Croce

Department of Cancer Biology and Genetics and Comprehensive Cancer Center, The Ohio State University